Zhang H - Search Results

1

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Zhang H, Zheng Z, Zhang R, Yan Y, Peng Y, Ye H, Lin L, Xu J, Li W, Huang P. Zhang H, et al. Among authors: zhang r. Cell Death Dis. 2021 Aug 16;12(9):793. doi: 10.1038/s41419-021-04071-2. Cell Death Dis. 2021. PMID: 34400616 Free PMC article. No abstract available.

2

Long-term results of the paraesophagogastric devascularization with or without esophageal transection: which is more suitable for variceal bleeding?

Zhang HY, Li WB, Ye H, Xiao ZY, Peng YR, Wang J. Zhang HY, et al. World J Surg. 2014 Aug;38(8):2105-12. doi: 10.1007/s00268-014-2478-2. World J Surg. 2014. PMID: 24590450

3

Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

Zhang H, Li W, Huang P, Lin L, Ye H, Lin D, Koeffler HP, Wang J, Yin D. Zhang H, et al. Oncol Rep. 2015 Mar;33(3):1481-92. doi: 10.3892/or.2015.3709. Epub 2015 Jan 8. Oncol Rep. 2015. PMID: 25571929

4

Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.

Huang P, Zhuang B, Zhang H, Yan H, Xiao Z, Li W, Zhang J, Tang Q, Hu K, Koeffler HP, Wang J, Yin D. Huang P, et al. Among authors: zhang j, zhang h. Clin Cancer Res. 2015 Oct 1;21(19):4420-30. doi: 10.1158/1078-0432.CCR-14-2067. Epub 2015 Jun 9. Clin Cancer Res. 2015. PMID: 26059188

5

CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.

Lin Z, Li W, Zhang H, Wu W, Peng Y, Zeng Y, Wan Y, Wang J, Ouyang N. Lin Z, et al. Among authors: zhang h. Tumour Biol. 2016 Mar;37(3):3461-8. doi: 10.1007/s13277-015-4172-x. Epub 2015 Oct 8. Tumour Biol. 2016. PMID: 26449829

6

Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection.

Hu Z, Li W, Huang P, Zhou Z, Xu J, Xu K, Wang J, Zhang H. Hu Z, et al. Among authors: zhang h. Int J Surg. 2017 Dec;48:23-31. doi: 10.1016/j.ijsu.2017.09.075. Epub 2017 Oct 5. Int J Surg. 2017. PMID: 28987561 Free article.

7

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.

Jiang H, Zhu Y, Zhou Z, Xu J, Jin S, Xu K, Zhang H, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: zhang h. Cancer Med. 2018 Mar;7(3):869-882. doi: 10.1002/cam4.1360. Epub 2018 Feb 14. Cancer Med. 2018. PMID: 29441724 Free PMC article.

8

PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.

Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. Jiang H, et al. Among authors: zhang h. Cancer Sci. 2018 May;109(5):1414-1427. doi: 10.1111/cas.13598. Cancer Sci. 2018. PMID: 29603830 Free PMC article.

9

Safety and efficacy of dehydrated ethanol soaking of the operative field in the treatment of spontaneous hepatocellular carcinoma rupture.

Sun J, Zhu Y, Peng YR, Li WB, Zhang HY, Zhou ZY, Wang L, Ma AD, Wang J. Sun J, et al. World J Surg Oncol. 2018 Apr 26;16(1):86. doi: 10.1186/s12957-018-1390-x. World J Surg Oncol. 2018. PMID: 29699571 Free PMC article.

10

CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

Zhou Z, Peng Y, Wu X, Meng S, Yu W, Zhao J, Zhang H, Wang J, Li W. Zhou Z, et al. Among authors: zhang h. Cell Oncol (Dordr). 2019 Feb;42(1):81-92. doi: 10.1007/s13402-018-0410-8. Epub 2018 Oct 1. Cell Oncol (Dordr). 2019. PMID: 30276551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130,618 results

Search Page

Filters